The Xelox 1 is part of Astech’s X-Product range. Operating as a stand-alone workstation for automated waste firing of inhalers and dose collection for particle size determination by NGI, the Xelox 1 Series now incorporates multiple ‘DUSA’ dose collection chambers so that additional inhaler shots can be taken for content uniformity testing. This company says this makes the Xelox 1 Series a more versatile and cost-effective dose collection solution.
Once loaded into the workstation, inhaler functions are performed automatically. Discrete automation modules enable cap removal, inhaler actuation, shaking, waste firing and dose collection for content uniformity and particle size determination.
DPI, BAI and MDI inhaler variants are accommodated. Data associated with actuation force, actuation distance, dose counter readings and critical flow parameters can all be recorded.
The Xelox 1 Series offers significant cost reductions compared with manual laboratory testing, allowing analysts to focus on more value-added tasks, says the Runcorn, Cheshire, UK-based company. The workstation also reduces the potential for work related upper limb disorders (WR-ULD), often associated with this type of testing.
Astech’s X-Products series includes the Xelair (DCU), Xelize (ACI) and Xelox (NGI) systems. They are available in a range of scalable platforms and can be configured for any inhaler type.
